Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 1,103,010	$ 428,430
Short-term investments	251,782	1,247,820
Accounts receivable, net	601,988	400,327
Inventory	749,960	322,859
Manufacturing-related deposits and prepaids	276,262	102,181
Other current assets	90,461	77,714
Total current assets	3,073,463	2,579,331
Property and equipment, net	340,336	227,154
Right of use assets	148,310	129,952
Non-current inventory	187,986	191,368
Non-current investments	133,163	0
Other non-current assets	79,915	136,771
Total assets	3,963,173	3,264,576
Current liabilities:
Accounts payable	214,442	164,918
Accrued expenses	373,513	314,997
Deferred revenue, current portion	130,256	50,416
Current portion of long-term debt	0	105,483
Other current liabilities	13,473	17,845
Total current liabilities	731,684	653,659
Long-term debt	1,137,124	1,132,515
Lease liabilities, net of current portion	192,473	140,965
Deferred revenue, net of current portion	325,000	437,000
Contingent consideration	47,400	38,100
Other non-current liabilities	1,750	3,000
Total liabilities	2,435,431	2,405,239
Commitments and contingencies (Note 22)
Stockholders’ equity:
Preferred stock, $0.0001 par value, 3,333,333 shares authorized; none issued and outstanding	0	0
Common stock, $0.0001 par value, 198,000,000 shares authorized; 96,900,496 and 93,731,831 issued and outstanding at December 31, 2024 and 2023, respectively	10	9
Additional paid-in capital	5,738,924	5,304,623
Accumulated other comprehensive (loss) income, net of tax	(218)	918
Accumulated deficit	(4,210,974)	(4,446,213)
Total stockholders’ equity	1,527,742	859,337
Total liabilities and stockholders’ equity	$ 3,963,173	$ 3,264,576